The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.00
Bid: 75.00
Ask: 79.00
Change: 0.00 (0.00%)
Spread: 4.00 (5.333%)
Open: 77.00
High: 77.00
Low: 77.00
Prev. Close: 77.00
CRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Crystal Amber requisitions De La Rue plc GM

31 Mar 2023 07:00

RNS Number : 8512U
Crystal Amber Fund Limited
31 March 2023
 

Reach announcement*

 

31 March 2023

 

CRYSTAL AMBER FUND LIMITED

("Crystal Amber", the "Company", or the "Fund")

 

Crystal Amber Fund Limited requisitions general meeting at De La Rue plc to replace Chairman and appoint a new director as Chairman

 

Crystal Amber, the activist investment fund, announces that it has sent to the board of De La Rue plc ("De La Rue") a requisition notice requiring De La Rue to convene a general meeting at which a resolution will be proposed to remove Non-Executive Director and Chairman Kevin Loosemore ("the Requisition"). The Requisition also proposes to appoint Pepyn Dinandt as a Non-Executive Director and Chairman. Details relating to Pepyn Dinandt are set out below in Appendix 1.

 

Background and reasons for the Requisition:

 

1. Since 2018, Crystal Amber has been a shareholder in De La Rue. Crystal Amber currently holds approximately 9.8% of the total issued share capital of De La Rue. 

 

2. Crystal Amber notes that De La Rue's current market capitalisation is £103 million. This is after the July 2020 equity fundraise of £100 million, meaning that since July 2020, the like-for-like valuation of the business has fallen to £3 million. Prior to the fundraise, the market capitalisation was £125 million. 

 

3. Crystal Amber notes that on page 14 of De La Rue's interim results released in November 2022, a reference was made to a material uncertainty going concern audit qualification. This relates to potential banking covenant breaches.

 

4. Crystal Amber notes that in December 2022, it wrote to the directors of De Le Rue in a personal capacity. In that letter, Crystal Amber highlighted several specific concerns, including the effect on revenues and profits of making 300 staff redundant at the Kenyan print facility and ceasing print operations. The directors of De La Rue wrote to Crystal Amber to deny this. However, on 20 January 2023, De La Rue announced the closure of its Kenyan print facilities. Whilst the announcement said that this closure was not expected to affect revenues to 31 March 2023, it made no reference to the effect on revenues for the year commencing on 1 April 2023. Prior to the closure of the Kenyan print facilities, the revenue from Kenya comprised around 12% of total revenues from the Currency division of De La Rue.

 

5. Crystal Amber notes that in the period to 26 March 2022, after the £36 million cost cutting, De La Rue's pre-tax profits from continuing operations were £24.2 million. The current market consensus estimate for the year to 31 March 2023 for De La Rue is for pre-tax profits of £22 million.

 

6. Crystal Amber believes that unless it takes immediate action, De La Rue's audit report for the year to March 2023 is likely to include a material uncertainty going concern qualification. This could have an adverse impact on De La Rue, not only as regards tendering for new contracts but importantly for retaining existing customers and contracts.

 

7. Crystal Amber believes that an immediate change of leadership is required. Therefore, it has concluded that it is necessary to replace Non-Executive Director and Chairman Kevin Loosemore. Crystal Amber believes that Pepyn Dinandt should replace Kevin Loosemore as Non-Executive Director and Chairman. Further details relating to Pepyn Dinandt are set out below in Appendix 1.

 

8. Crystal Amber notes that De La Rue has a rich history and long-established reputation within banknote printing. With a broad range of central bank customers, it is naturally placed to lead industry growth, given the right strategy and operational execution. This Requisition seeks to honour these characteristics and the strategic value they give to De La Rue and to protect them for De la Rue's shareholders and stakeholders.

 

Appendix 1

 

Pepyn Dinandt has spent almost 20 years working on behalf of and with private equity firms including KKR, Apollo and Towerbrook. He has a long and successful track record in building businesses by delivering on value creation programs and securing exits. He is currently Chief Executive of the Climate Control Systems and Automotive Controls division at the Eberspaecher Group, a very large family-owned Tier 1 automotive supplier. By the end of 2023, this global division is forecast to have approximately €900 million revenues and 3,500 employees.

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

 

Allenby Capital Limited - Nominated Adviser

David Worlidge/Jeremy Porter/Dan Dearden-Williams

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

*About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAURRWROAUOOAR
Date   Source Headline
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20245:30 pmRNSTransaction in Own Shares
11th Mar 20244:59 pmRNSTransaction in Own Shares
7th Mar 20245:38 pmRNSTransaction in Own Shares
29th Feb 20245:30 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Interim Results and Portfolio Update
27th Feb 20247:00 amRNSDirector/PDMR Dealing
26th Feb 20244:45 pmRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20246:02 pmRNSTransaction in Own Shares
22nd Feb 20249:28 amRNSMonthly Net Asset Value
22nd Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20245:20 pmRNSTransaction in Own Shares
13th Feb 20245:41 pmRNSHolding(s) in Company
2nd Feb 20246:17 pmRNSTransaction in Own Shares
1st Feb 20246:14 pmRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTotal Voting Rights and Transaction in Own Shares
30th Jan 20249:47 amRNSHolding(s) in Company
30th Jan 20249:41 amRNSHolding(s) in Company
29th Jan 20245:20 pmRNSExtension to Share Buyback Programme
26th Jan 20245:47 pmRNSTransaction in Own Shares
25th Jan 20247:00 amRNSReplacement - Director/PDMR Shareholding
24th Jan 20245:32 pmRNSTransaction in Own Shares
24th Jan 20249:01 amRNSDirector/PDMR Shareholding
24th Jan 20248:22 amRNSDirector/PDMR Shareholding
23rd Jan 20245:45 pmRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSHolding(s) in Company
22nd Jan 20245:37 pmRNSTransaction in Own Shares
22nd Jan 20244:38 pmRNSMonthly Net Asset Value
19th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20245:30 pmRNSTransaction in Own Shares
16th Jan 20245:34 pmRNSTransaction in Own Shares
15th Jan 20245:31 pmRNSTransaction in Own Shares
11th Jan 20245:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.